ICMR Study Reveals Four Or More Dosages Of Hydroxychloroquine Reduces COVID-19 Risk In Health WorkersAnti-malarial drug hydroxychloroquine

A case-controlled investigation of the Indian Council of Medical Research (ICMR) has revealed that consumption of four or more maintenance doses of hydroxychloroquine has led to a significant decline in the chances of the health workers getting infected with COVID-19, reports India Today.

The study reveals that while simply initiating exposure to hydroxychloroquine prophylaxis did not reduce the odds, however, it was observed that the protective effects of the drug began to show after taking in four or more doses.

Scientists involved in the study have noticed that fourth week onwards the risk reduction is observed to be significant if it is taken as prescribed for seven weeks.

The data for the study was collected between 8 to 23 May and involved doctors, nurses, housekeeping staff, security guards, laboratory technicians and operation theatre technicians.

It should be noted that the ICMR study's backing of the usage of the drug comes even as the World Health Organisation (AHO)'s solidarity trials of the drug have been put on pause to review the safety data.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber